Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case

[ad_1] Updated Nov. 20, 2023 3:16 pm ET Bayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and…

Earnings call: REGENXBIO unveils strategic plan, positive clinical data, and corporate restructuring By Investing.com

[ad_1] In their third quarter 2023 earnings call, biotechnology company REGENXBIO announced an updated strategic plan, positive clinical data from priority programs, and a corporate restructuring plan. The company is…

Achieving Clinical Trial Diversity: Expanding Hospital Capacity To Offer Trials In The Community – Healthcare – United States

[ad_1] Editor’s Note: In our recent white paper, Achieving Clinical Trial Diversity: Expanding Hospital Capacity to Offer Trials in the Community, Manatt Health discusses the important role of community hospitals…

Achieving Clinical Trial Diversity: Expanding Hospital Capacity to Offer Trials in the Community | JD Supra

[ad_1] Editor’s Note: In our recent white paper, Achieving Clinical Trial Diversity: Expanding Hospital Capacity to Offer Trials in the Community, Manatt Health discusses the important role of community hospitals and health…

Ascendis Presents Updated and New TransCon™ IL-2 β⁄γ Monotherapy and Combination Therapy Data Confirming Clinical Activity Across Tumor Types at ESMO 2023 | BioSpace

[ad_1] —  Clinical responses with TransCon IL-2 β⁄γ demonstrated as monotherapy or in combination with checkpoint inhibitor, including in two of three small cell lung cancer patients treated with combination therapy — TransCon…

T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference

[ad_1] T2 Biosystems, Inc. Data demonstrates speed, accuracy, and clinical benefits of the T2Dx Instrument and T2 Biosystems’ sepsis panels, including encouraging early detection data for T2Resistance Panel LEXINGTON, Mass.,…

Decentralized Clinical Trials: Book Of Case Studies

[ad_1] The FDA characterizes a decentralized clinical trial (DCT) as a clinical investigation in which some or all trial-related activities take place at a location separate from the investigator’s site.…

Welcome to Clinical Congress 2023

[ad_1] …

New Data Presented at EACS 2023 Further Demonstrate Strong Clinical Profile of Twice-Yearly Sunlenca® for Adults With Multi-Drug Resistant HIV

[ad_1] – Two-Year Resistance Analysis from CAPELLA Pivotal Trial Reinforces Sunlenca as a Person-Centered Option in Combination with an Optimized Background Regimen – – Latest Research Highlights the Potential Impact…

Global Cell Surface Markers Strategic Business Report 2023-2030: Research Dominates Cell Surface Markers Market, Clinical Diagnostics to Exhibit Fastest Growth

[ad_1] Dublin, Oct. 20, 2023 (GLOBE NEWSWIRE) — The “Cell Surface Markers – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Cell Surface Markers Market to…